Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
Liver DysfunctionLiver Metastasis Colon CancerLiver Regeneration
Interventions
DRUG

High-Dose Insulin Therapy

A baseline blood glucose value will be obtained. Two units of insulin will be administered IV if the blood glucose is \> mmol/L. An insulin infusion of 0.12 units/kg/hr will be started. Ten minutes after starting the insulin, and when the blood glucose is \< 6 mmol/L, dextrose 20% supplemented with phosphate (30 mmol/L) will be infused. Blood glucose levels will be measured every 15 minutes, and the dextrose infusion rate adjusted to maintain glycemic levels between 4 and 6 mmol/L for a duration of 6 hours. At the end of the 6 hour period, the insulin will be stopped and the dextrose will be weaned off.

Trial Locations (1)

H3A 1A1

RECRUITING

McGill Univeristy Health Centre, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER